Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
134 In addition, a clinically significant DDI was reported in a Phase I study of ALRN-6924, an analog of ATSP-7041 and an inhibitor of OATP1B3
This scheduling allows researchers to manage multiple experimental phases or coordinate with institutional protocols
M., & Bertolini, G
Due to our limited resources and access to capital, we must, and have in the past decided to, prioritize development of certain product candidates over other potential product candidates
, 20-30
US$ 29.31
US$ 27.20
US$ 20.77
US$ 20.09
